Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jan 17 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-17-2024-5

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 17, 2024, titled "Zydus receives Final Approvals from the USFDA for Pimavanserin Capsules, 34 mg and Pimavanserin Tablets,10 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases